Clinical Trial Update: bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC [NA]

View source ↗

Summary

A clinical trial is evaluating balloon-occluded transarterial embolization with hepatic arterial infusion chemotherapy (bTAE-HAIC) plus systemic therapy for int…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Camrelizumab (camrelizumab)
• LENVIMA (lenvatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Liver Diseases, Hepatocellular Carcinoma | NA | Status: RECRUITING